Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 282

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues

Nissan, Aviram, Stojadinovic, Alexander, Mitrani‐Rosenbaum, Stella, Halle, David, Grinbaum, Ronit, Roistacher, Marina, Bochem, Andrea, Dayanc, Baris Emre, Ritter, Gerd, Gomceli, Ismail, Bostanci, Erdal Birol, Akoglu, Musa, Chen, Yao‐Tseng, Old, Lloyd John, Gure, Ali Osmay·2012·International Journal of Cancer

Abstract

Early detection of colorectal cancer (CRC) is currently based on fecal occult blood testing (FOBT) and colonoscopy, both which can significantly reduce CRC‐related mortality. However, FOBT has low‐sensitivity and specificity, whereas colonoscopy is labor‐ and cost‐intensive. Therefore, the discovery of novel biomarkers that can be used for improved CRC screening, diagnosis, staging and as targets for novel therapies is of utmost importance. To identify novel CRC biomarkers we utilized representational difference analysis (RDA) and characterized a colon cancer associated transcript (CCAT1), demonstrating consistently strong expression in adenocarcinoma of the colon, while being largely undetectable in normal human tissues (p < 000.1). CCAT1 levels in CRC are on average 235‐fold higher than those found in normal mucosa. Importantly, CCAT1 is strongly expressed in tissues representing the early phase of tumorigenesis: in adenomatous polyps and in tumor‐proximal colonic epithelium, as well as in later stages of the disease (liver metastasis, for example). In CRC‐associated lymph nodes, CCAT1 overexpression is detectable in all H&E positive, and 40.0% of H&E and immunohistochemistry negative lymph nodes, suggesting very high sensitivity. CCAT1 is also overexpressed in 40.0% of peripheral blood samples of patients with CRC but not in healthy controls. CCAT1 is therefore a highly specific and readily detectable marker for CRC and tumor‐associated tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.26170

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 282

Metadata

Authors
Nissan, A., Stojadinovic, A., Mitrani‐Rosenbaum, S., Halle, D., Grinbaum, R., Roistacher, M., Bochem, A., Dayanc, B. E., Ritter, G., Gomceli, I., Bostanci, E. B., Akoglu, M., Chen, Y., Old, L. J., & Gure, A. O.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2011-08-02
Volume
130
Issue
7
Pages
1598-1606
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2093007278
Cited by
282
References
28
FWCI
1.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues. https://app.cochat.ai/papers/10.1002/ijc.26170
The paper
Nissan, A., Stojadinovic, A., Mitrani‐Rosenbaum, S., Halle, D., Grinbaum, R., Roistacher, M., Bochem, A., Dayanc, B. E., Ritter, G., Gomceli, I., Bostanci, E. B., Akoglu, M., Chen, Y., Old, L. J., & Gure, A. O. (2012). Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues. International Journal of Cancer. https://doi.org/10.1002/ijc.26170

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.